AIMS: In a nationwide sample of patients with type 2 diabetes we assessed the prevalence of complications and compliance with current guidelines. METHODS: We recruited a randomly selected sample of 534 men and 441 women aged 18-75 years with type 2 diabetes. A single visit review of medical records, interview, physical examination and laboratory tests was collected. RESULTS: The WHO criteria for the metabolic syndrome were met by 79% [74%, 84%]. Thirty percent [28%, 33%] had a history of cardiovascular disease, 13% [11%, 16%] had microalbuminuria, 15% [13%, 18%] had retinopathy, and 23% [21%, 26%] had peripheral neuropathy assessed by a monofilament test. Erectile dysfunction was common (43% [38%, 47%]). Two thirds met the national treatment target for glycaemia (HbA1c <7.5%), one-half the blood pressure target (BP <140/85mmHg), and one-third the target for lipids (total/HDL cholesterol <4). However, only 13% reached the combined targets for glucose, blood pressure and cholesterol control. CONCLUSIONS: The classical microvascular complications of diabetes affected a minority of participants while the metabolic syndrome affected the majority. The gap between guidelines and current clinical practice was substantial given that only one of eight patients reached the combined goals for glycaemia, blood pressure and lipid control.
AIMS: In a nationwide sample of patients with type 2 diabetes we assessed the prevalence of complications and compliance with current guidelines. METHODS: We recruited a randomly selected sample of 534 men and 441 women aged 18-75 years with type 2 diabetes. A single visit review of medical records, interview, physical examination and laboratory tests was collected. RESULTS: The WHO criteria for the metabolic syndrome were met by 79% [74%, 84%]. Thirty percent [28%, 33%] had a history of cardiovascular disease, 13% [11%, 16%] had microalbuminuria, 15% [13%, 18%] had retinopathy, and 23% [21%, 26%] had peripheral neuropathy assessed by a monofilament test. Erectile dysfunction was common (43% [38%, 47%]). Two thirds met the national treatment target for glycaemia (HbA1c <7.5%), one-half the blood pressure target (BP <140/85mmHg), and one-third the target for lipids (total/HDL cholesterol <4). However, only 13% reached the combined targets for glucose, blood pressure and cholesterol control. CONCLUSIONS: The classical microvascular complications of diabetes affected a minority of participants while the metabolic syndrome affected the majority. The gap between guidelines and current clinical practice was substantial given that only one of eight patients reached the combined goals for glycaemia, blood pressure and lipid control.
Authors: Anne Helen Hansen; Meghan Bradway; Jan Broz; Tor Claudi; Øystein Henriksen; Silje C Wangberg; Eirik Årsand Journal: JMIR Res Protoc Date: 2016-10-31
Authors: John Graham Cooper; Tor Claudi; Anne Karen Jenum; Geir Thue; Marie Fjelde Hausken; Wibeche Ingskog; Sverre Sandberg Journal: Diabetes Care Date: 2008-10-13 Impact factor: 17.152
Authors: Hanne Strøm; Randi Selmer; Kåre I Birkeland; Henrik Schirmer; Tore Julsrud Berg; Anne Karen Jenum; Kristian Midthjell; Christian Berg; Lars Christian Stene Journal: BMC Public Health Date: 2014-05-29 Impact factor: 3.295
Authors: Karianne Fjeld Løvaas; John G Cooper; Sverre Sandberg; Thomas Røraas; Geir Thue Journal: BMC Health Serv Res Date: 2015-12-15 Impact factor: 2.655